Normative data and psychometric properties of the Patient Health Questionnaire-9 in a nationally representative Korean population.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
30 04 2020
Historique:
received: 20 12 2019
accepted: 20 04 2020
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 27 10 2020
Statut: epublish

Résumé

The Patient Health Questionnaire-9 (PHQ-9) has been standardized in several populations and is widely used in clinical practice and health care. However, it has not been appropriately standardized in the Korean general population, and no normative data have been presented. The aim of this study was to provide the normative data and psychometric properties of the PHQ-9 in the nationally representative population of Korea. We used the nationwide cross-sectional survey data of Korea from 2014 to 2016. The data of 10,759 individuals aged over 19 years were analyzed in this study. As the distribution of the PHQ-9 scores was not normative, the percentile ranks for raw scores were provided. The survey questionnaires included the PHQ-9, The EuroQol-5 Dimension (EQ-5D), and demographic characteristics. We analyzed the construct validity and internal consistency of the PHQ-9. The normative data of the PHQ-9 were generated according to the sex and different age categories. The correlation coefficient between the sum of the PHQ-9 scores and the EQ-5D index was 0.44, which was moderate. The most appropriate model was the two-factor model with five 'affective-somatic' labeled items and four 'cognitive' labeled items. Cronbach's α for the PHQ-9 was 0.79. Our result supports reliability and validity with two-factor structure of PHQ-9 for measuring depression in the Korean nationally representative population. The Korean normative data on the PHQ-9 according to percentile rank can assist in interpreting and comparing scores with other populations.

Sections du résumé

BACKGROUND
The Patient Health Questionnaire-9 (PHQ-9) has been standardized in several populations and is widely used in clinical practice and health care. However, it has not been appropriately standardized in the Korean general population, and no normative data have been presented. The aim of this study was to provide the normative data and psychometric properties of the PHQ-9 in the nationally representative population of Korea.
METHODS
We used the nationwide cross-sectional survey data of Korea from 2014 to 2016. The data of 10,759 individuals aged over 19 years were analyzed in this study. As the distribution of the PHQ-9 scores was not normative, the percentile ranks for raw scores were provided. The survey questionnaires included the PHQ-9, The EuroQol-5 Dimension (EQ-5D), and demographic characteristics. We analyzed the construct validity and internal consistency of the PHQ-9.
RESULTS
The normative data of the PHQ-9 were generated according to the sex and different age categories. The correlation coefficient between the sum of the PHQ-9 scores and the EQ-5D index was 0.44, which was moderate. The most appropriate model was the two-factor model with five 'affective-somatic' labeled items and four 'cognitive' labeled items. Cronbach's α for the PHQ-9 was 0.79.
CONCLUSIONS
Our result supports reliability and validity with two-factor structure of PHQ-9 for measuring depression in the Korean nationally representative population. The Korean normative data on the PHQ-9 according to percentile rank can assist in interpreting and comparing scores with other populations.

Identifiants

pubmed: 32354339
doi: 10.1186/s12888-020-02613-0
pii: 10.1186/s12888-020-02613-0
pmc: PMC7193414
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Références

Front Psychiatry. 2018 Aug 23;9:390
pubmed: 30190687
BMJ. 2019 Apr 8;365:l794
pubmed: 30962184
J Affect Disord. 2004 Oct 15;82(2):271-6
pubmed: 15488257
Multivariate Behav Res. 1990 Apr 1;25(2):173-80
pubmed: 26794479
J Nerv Ment Dis. 2014 Apr;202(4):280-6
pubmed: 24647214
Compr Psychiatry. 2012 Jan;53(1):95-102
pubmed: 21193179
Depress Anxiety. 2004;19(3):137-45
pubmed: 15129415
J Clin Psychol. 2015 Sep;71(9):898-907
pubmed: 25950150
Clin Neuropsychol. 2009 Sep;23(7):1173-95
pubmed: 19322734
Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):539-44
pubmed: 25023953
Fam Med. 1990 Jul-Aug;22(4):307-11
pubmed: 2200734
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):551-5
pubmed: 23664569
J Behav Med. 2003 Apr;26(2):119-32
pubmed: 12776382
Qual Life Res. 2005 Jun;14(5):1401-6
pubmed: 16047514
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Int J Epidemiol. 2014 Feb;43(1):69-77
pubmed: 24585853
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
J Korean Med Sci. 2015 Nov;30(11):1659-66
pubmed: 26539012
Int J Methods Psychiatr Res. 2003;12(1):22-33
pubmed: 12830307
J Affect Disord. 2014 Mar;156:104-10
pubmed: 24388684
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Affect Disord. 2011 Nov;134(1-3):444-7
pubmed: 21665288
J Headache Pain. 2015;16:65
pubmed: 26174509
Psychosom Med. 2007 Nov;69(8):735-9
pubmed: 17942844
Compr Psychiatry. 2008 Mar-Apr;49(2):218-23
pubmed: 18243897
J Korean Med Sci. 2012 May;27 Suppl:S70-5
pubmed: 22661875
Value Health. 2009 Nov-Dec;12(8):1187-93
pubmed: 19659703
J Psychosom Res. 2013 Jul;75(1):60-4
pubmed: 23751240
Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3-7
pubmed: 21750622
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):733-9
pubmed: 23703492
Psychol Med. 2010 Feb;40(2):225-37
pubmed: 19531277
J Korean Med Sci. 2017 Nov;32(11):1861-1869
pubmed: 28960042
Gen Hosp Psychiatry. 2014 May-Jun;36(3):330-6
pubmed: 24462337
J Affect Disord. 2012 Nov;140(3):205-14
pubmed: 22244375
Gen Hosp Psychiatry. 2008 May-Jun;30(3):191-9
pubmed: 18433651
Psychol Med. 2003 Feb;33(2):357-62
pubmed: 12622315
Eur Psychiatry. 2000 May;15(3):160-72
pubmed: 10881213
Health Econ. 2016 Oct;25(10):1239-51
pubmed: 26085120
J Korean Med Sci. 2011 Jan;26(1):1-10
pubmed: 21218022
CMAJ. 2017 Oct 23;189(42):E1304-E1310
pubmed: 29061855
Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7
pubmed: 16377369
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Health Qual Life Outcomes. 2015 Dec 23;13:203
pubmed: 26694964

Auteurs

Cheolmin Shin (C)

Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, 15355, Republic of Korea.

Young-Hoon Ko (YH)

Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, 15355, Republic of Korea.

Hyonggin An (H)

Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea.

Ho-Kyoung Yoon (HK)

Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, 15355, Republic of Korea.

Changsu Han (C)

Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, 15355, Republic of Korea. hancs@korea.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH